BeiGene, Ltd.

Director, Clinical Biomarkers & Translational Medicine – Oncology (Solid Tumor Portfolio)

BeiGene, Ltd.$176K — $236K *
US-Anywhere
+ 2 other locationsRemote
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • 5+ years in oncology drug development within the pharmaceutical or biotechnology industry.
  • Proven track record in leading biomarker and translational medicine strategies across clinical phases.
  • Experienced in developing biomarker strategies for advanced therapies like targeted and immuno-oncology.
  • Familiarity with companion diagnostic development is a plus.
  • Competence in regulatory submissions related to biomarkers and precision medicine.

Responsibilities

  • Lead biomarker strategy development from First-in-Human through registration stages.
  • Drive the execution of biomarker strategies for patient selection and pharmacodynamic assessments.
  • Integrate diverse datasets to inform and refine clinical development strategies.
  • Provide leadership in biomarker regulatory activities and documentation.
  • Forge strategic partnerships with academic and industrial entities for biomarker development.
  • Represent BeOne Medicines at scientific forums and collaborate in research consortia.
  • Publish and present significant research findings in notable journals and conferences.

Benefits

  • Comprehensive medical, dental, and vision coverage.
  • 401(k) retirement plan with company contributions.
  • Flexible spending accounts (FSA) and health savings accounts (HSA) options.
  • Life insurance and wellness benefits.
  • Paid time off to promote work-life balance.
  • Equity awards and participation in the Employee Stock Purchase Plan.
Full Job Description

BeOne Medicines is seeking an accomplished scientific leader to serve as Director, Clinical Biomarkers & Translational Medicine within the Oncology organization. This individual will lead the development and implementation of integrated translational medicine and clinical biomarker strategies across a portfolio of innovative solid tumor programs spanning early- and late-stage clinical development.

The successful candidate will serve as the translational and biomarker lead for assigned programs, partnering closely with Discovery Research, Clinical Development, Clinical Pharmacology, Precision Medicine, Bioinformatics, Biostatistics, Regulatory Affairs, Diagnostics, Medical Affairs, and external collaborators to accelerate biomarker-driven drug development and enable data-driven clinical decision making.

Essential Functions of the Job:

Clinical Biomarker Strategy and Clinical Development

  • Lead the development and execution of integrated translational medicine and clinical biomarker strategies from First-in-Human through registration for assigned oncology programs.

    • Develop biomarker strategies supporting patient selection and enrichment; pharmacodynamic assessments, including target engagement; mechanism of action and mechanisms of sensitivity and resistance; dose optimization; prognostic and predictive biomarker development

  • Ensure biomarker plans are scientifically rigorous, operationally feasible, and aligned with overall clinical development objectives.

  • Integrate and interpret clinical, molecular, pharmacologic, and translational datasets to generate biological insights that inform program strategy, clinical development decisions, and portfolio prioritization.

  • Provide scientific leadership for biomarker-related regulatory activities.

  • Establish and manage strategic collaborations with academic investigators, contract research organizations, central laboratories, and diagnostic partners.

  • Represent BeOne Medicines at scientific meetings, external collaborations, and consortium activities.

  • Drive publication and presentation of high-impact translational and biomarker research in peer-reviewed journals and scientific congresses.

Experience

  • Minimum of five years of pharmaceutical or biotechnology industry experience in oncology drug development, including substantial experience leading clinical biomarker and translational medicine strategies.

  • Demonstrated success supporting biomarker strategy across Phase I–III oncology clinical development.

  • Experience developing biomarker strategies for targeted therapies, immuno-oncology agents, and/or antibody-drug conjugates.

  • Experience supporting companion diagnostic development is highly desirable.

  • Experience contributing to regulatory submissions involving biomarkers and precision medicine is preferred.

Scientific Expertise

  • Deep expertise in translational oncology and clinical biomarker science.

    • Working knowledge of modern translational technologies, including:  next-generation sequencing (NGS), RNA sequencing, ctDNA, multiplex immunohistochemistry, digital pathology, proteomics, flow cytometry, single-cell technologies, emerging multi-omics approaches/data integration and computational biology

Leadership Competencies

The successful candidate will demonstrate:

  • Strategic scientific leadership with the ability to influence multidisciplinary teams in a global matrix environment.

  • Strong scientific judgment and data-driven decision-making.

  • Excellent written and verbal communication skills.

  • Proven ability to build productive external scientific collaborations.

  • Strong publication record and recognized scientific credibility within the oncology community.

  • Passion for innovation and advancing precision oncology to improve patient outcomes.

  • Knowledge of Mandarin is beneficial but not required.

Education Required:

  • PhD, MD, PharmD, or MD/PhD in Oncology, Molecular Biology, Immunology, Cancer Biology, Pharmacology, or a related scientific discipline.

Global Competencies

When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.

  • Fosters Teamwork
  • Provides and Solicits Honest and Actionable Feedback
  • Self-Awareness
  • Acts Inclusively
  • Demonstrates Initiative
  • Entrepreneurial Mindset
  • Continuous Learning
  • Embraces Change
  • Results-Oriented
  • Analytical Thinking/Data Analysis
  • Financial Excellence
  • Communicates with Clarity

Salary Range: $176,600.00 - $236,600.00 annually

BeOne is committed to fair and equitable compensation practices. Actual compensation packages are determined by several factors that are unique to each candidate, including but not limited to job-related skills, depth of experience, certifications, relevant education or training, and specific work location. Packages may vary by location due to differences in the cost of labor. The recruiter can share more about the specific salary range for a preferred location during the hiring process.  Please note that the listed range reflects the base salary or hourly range only. Non-Commercial roles are eligible to participate in the annual bonus plan, and Commercial roles are eligible to participate in an incentive compensation plan. All Company employees have the opportunity to own shares of BeOne Medicines Ltd. stock because all employees are eligible for discretionary equity awards and to voluntarily participate in the Employee Stock Purchase Plan. The Company has a comprehensive benefits package that includes Medical, Dental, Vision, 401(k), FSA/HSA, Life Insurance, Paid Time Off, and Wellness.

About BeiGene, Ltd.

BeiGene, Ltd. is a biotechnology company that develops and commercializes innovative cancer treatments. The company was founded in 2010 and is headquartered in George Town, Grand Cayman. BeiGene's portfolio includes several drug candidates that target cancer cells and the tumor microenvironment. The company's lead product, Brukinsa, is a treatment for mantle cell lymphoma that has been approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). BeiGene also has partnerships with several pharmaceutical companies, including Amgen, Merck, and Novartis.
Learn more about BeiGene, Ltd.
Size
8,300 employees
Market Cap
$22.2 billion
Industry
Net Income
-$1.5 billion
Founded
2010
5 Year Trend
+305.7%
Revenue
$308.8 million
NASDAQ

Similar Jobs

More Jobs at BeiGene, Ltd.

More Pharmaceuticals & Biotech Jobs

Find similar Director, Clinical Biomarkers & Translational Medicine – Oncology (Solid Tumor Portfolio) jobs: